| Abstrakt: |
Background Curcumin has anti-inflammatory properties. The aim of this study was to compare interleukin-1β ( IL-1β) and chemokine (C-C motif) ligand 28 ( CCL28) levels following a topical application of curcumin ( CRM), chlorhexidine ( CHX) and chlorhexidine-metronidazole ( CHX- MTZ) in an experimental gingivitis human model. Methods Sixty systemically healthy selected subjects were randomly assigned to one of three topical antigingivitis gels. Each gel was applied twice daily for 10 minutes as the sole method of oral hygiene for 29 days on the test quadrant only. Modified gingival index ( MGI), plaque index ( PI), bleeding on probing ( BOP) and probing depth ( PD) were assessed at baseline, 29 days and 60 days. Estimation of IL-1β and CCL28 levels in gingival crevicular fluid was done at baseline and at 29 days. Results The increase of IL-1β in the CRM (14.52 ± 16.6 pg/ml) and CHX- MTZ (31.63 ± 15.96) groups was significantly less than that of the CHX group (70.55 ± 38.81). Similar results were also observed for CCL28 ( CRM: 8.12 ± 8.78 pg/ml; CHX- MTZ: 12.81 ± 18.68; CHX: 41.15 ± 22.82). All groups had a significant increase in MGI, PI and BOP at 29 days. Conclusions The anti-inflammatory potential of topical curcumin was similar to CHX- MTZ but superior to CHX in affecting IL-1β and CCL28 levels. [ABSTRACT FROM AUTHOR] |
Plný text